{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:51:47Z","timestamp":1791287507519,"version":"4.1.0"},"reference-count":124,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["Nos2020YFC2009000"],"award-info":[{"award-number":["Nos2020YFC2009000"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-026-04773-7","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:39:53Z","timestamp":1791279593000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cardiovascular safety in middle-aged and older men under testosterone replacement therapy: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"91","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-4976-0497","authenticated-orcid":false,"given":"Hongzhuo","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqi","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaojiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieyu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinyu","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiyue","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaokai","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"key":"4773_CR1","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1210\/jcem.86.2.7219","volume":"86","author":"SM Harman","year":"2001","unstructured":"S.M. Harman, E.J. Metter, J.D. Tobin, J. Pearson, M.R. Blackman, Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J. Clin. Endocrinol. Metab. 86, 724\u2013731 (2001)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4773_CR2","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1210\/jc.2010-3012","volume":"96","author":"S Bhasin","year":"2011","unstructured":"S. Bhasin, M. Pencina, G.K. Jasuja, T.G. Travison, A. Coviello, E. Orwoll et al., Reference ranges for testosterone in men generated using liquid chromatography tandem mass spectrometry in a community-based sample of healthy nonobese young men in the Framingham Heart Study and applied to three geographically distinct cohorts. J. Clin. Endocrinol. Metab. 96, 2430\u20132439 (2011)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4773_CR3","doi-asserted-by":"publisher","first-page":"951","DOI":"10.7326\/0003-4819-133-12-200012190-00010","volume":"133","author":"S Amin","year":"2000","unstructured":"S. Amin, Y. Zhang, C.T. Sawin, S.R. Evans, M.T. Hannan, D.P. Kiel et al., Association of hypogonadism and estradiol levels with bone mineral density in elderly men from the Framingham study. Ann. Intern. Med. 133, 951\u2013963 (2000)","journal-title":"Ann. Intern. Med."},{"key":"4773_CR4","doi-asserted-by":"publisher","first-page":"E284","DOI":"10.1152\/ajpendo.00334.2001","volume":"283","author":"TA Roy","year":"2002","unstructured":"T.A. Roy, M.R. Blackman, S.M. Harman, J.D. Tobin, M. Schrager, E.J. Metter, Interrelationships of serum testosterone and free testosterone index with FFM and strength in aging men. Am. J. Physiol. Endocrinol. metabolism. 283, E284\u2013E294 (2002)","journal-title":"Am. J. Physiol. Endocrinol. metabolism"},{"key":"4773_CR5","doi-asserted-by":"crossref","unstructured":"S. Khosla, L.J. 3 Melton rd, R.A. Robb, J.J. Camp, E.J. Atkinson, A.L. Oberg et al., Relationship of volumetric BMD and structural parameters at different skeletal sites to sex steroid levels in men. J. bone mineral. research: official J. Am. Soc. Bone Mineral. Res. 20, 730\u2013740 (2005)","DOI":"10.1359\/JBMR.041228"},{"key":"4773_CR6","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.1365-2265.2007.02997.x","volume":"68","author":"LA Schaap","year":"2008","unstructured":"L.A. Schaap, S.M. Pluijm, D.J. Deeg, B.W. Penninx, B.J. Nicklas, P. Lips et al., Low testosterone levels and decline in physical performance and muscle strength in older men: findings from two prospective cohort studies. Clin. Endocrinol. 68, 42\u201350 (2008)","journal-title":"Clin. Endocrinol."},{"key":"4773_CR7","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1210\/jc.2009-2680","volume":"95","author":"JB Krasnoff","year":"2010","unstructured":"J.B. Krasnoff, S. Basaria, M.J. Pencina, G.K. Jasuja, R.S. Vasan, J. Ulloor et al., Free testosterone levels are associated with mobility limitation and physical performance in community-dwelling men: the Framingham Offspring Study. J. Clin. Endocrinol. Metab. 95, 2790\u20132799 (2010)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4773_CR8","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1172\/JCI84137","volume":"126","author":"JS Finkelstein","year":"2016","unstructured":"J.S. Finkelstein, H. Lee, B.Z. Leder, S.A. Burnett-Bowie, D.W. Goldstein, C.W. Hahn et al., Gonadal steroid-dependent effects on bone turnover and bone mineral density in men. J. Clin. Investig. 126, 1114\u20131125 (2016)","journal-title":"J. Clin. Investig."},{"key":"4773_CR9","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1001\/jama.295.11.1288","volume":"295","author":"EL Ding","year":"2006","unstructured":"E.L. Ding, Y. Song, V.S. Malik, S. Liu, Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. Jama. 295, 1288\u20131299 (2006)","journal-title":"Jama"},{"key":"4773_CR10","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.2337\/dc11-0888","volume":"34","author":"S Bhasin","year":"2011","unstructured":"S. Bhasin, G.K. Jasjua, M. Pencina, R. D\u2019Agostino, A.D. Sr., Coviello, R.S. Vasan et al., Sex hormone-binding globulin, but not testosterone, is associated prospectively and independently with incident metabolic syndrome in men: the framingham heart study. Diabetes care. 34, 2464\u20132470 (2011)","journal-title":"Diabetes care"},{"key":"4773_CR11","first-page":"4","volume":"4","author":"A Eleni","year":"2024","unstructured":"A. Eleni, Exploring the role of testosterone upon adiposity and cardiovascular risk markers in men with severe obesity. Metabolism Target. Organ. Damage. 4, 4 (2024)","journal-title":"Metabolism Target. Organ. Damage"},{"key":"4773_CR12","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1210\/jc.2011-1137","volume":"96","author":"AB Araujo","year":"2011","unstructured":"A.B. Araujo, J.M. Dixon, E.A. Suarez, M.H. Murad, L.T. Guey, G.A. Wittert, Clinical review: Endogenous testosterone and mortality in men: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 96, 3007\u20133019 (2011)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4773_CR13","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/cen.12997","volume":"84","author":"B Khazai","year":"2016","unstructured":"B. Khazai, S.H. Golden, L.A. Colangelo, R. Swerdloff, C. Wang, L. Honoris et al., Association of endogenous testosterone with subclinical atherosclerosis in men: the multi-ethnic study of atherosclerosis. Clin. Endocrinol. 84, 700\u2013707 (2016)","journal-title":"Clin. Endocrinol."},{"key":"4773_CR14","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1002\/gps.714","volume":"17","author":"E Hogervorst","year":"2002","unstructured":"E. Hogervorst, D.J. Lehmann, D.R. Warden, J. McBroom, A.D. Smith, Apolipoprotein E epsilon4 and testosterone interact in the risk of Alzheimer\u2019s disease in men. Int. J. Geriatr. Psychiatry. 17, 938\u2013940 (2002)","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"4773_CR15","doi-asserted-by":"publisher","first-page":"5001","DOI":"10.1210\/jc.2002-020419","volume":"87","author":"SD Moffat","year":"2002","unstructured":"S.D. Moffat, A.B. Zonderman, E.J. Metter, M.R. Blackman, S.M. Harman, S.M. Resnick, Longitudinal assessment of serum free testosterone concentration predicts memory performance and cognitive status in elderly men. J. Clin. Endocrinol. Metab. 87, 5001\u20135007 (2002)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4773_CR16","first-page":"203","volume":"24","author":"E Hogervorst","year":"2003","unstructured":"E. Hogervorst, M. Combrinck, A.D. Smith, Testosterone and gonadotropin levels in men with dementia. Neuroendocrinol. Lett. 24, 203\u2013208 (2003)","journal-title":"Neuroendocrinol. Lett."},{"key":"4773_CR17","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1212\/WNL.62.2.188","volume":"62","author":"SD Moffat","year":"2004","unstructured":"S.D. Moffat, A.B. Zonderman, E.J. Metter, C. Kawas, M.R. Blackman, S.M. Harman et al., Free testosterone and risk for Alzheimer disease in older men. Neurology. 62, 188\u2013193 (2004)","journal-title":"Neurology"},{"key":"4773_CR18","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1001\/jama.292.12.1431-b","volume":"292","author":"ER Rosario","year":"2004","unstructured":"E.R. Rosario, L. Chang, F.Z. Stanczyk, C.J. Pike, Age-related testosterone depletion and the development of Alzheimer disease. Jama. 292, 1431\u20131432 (2004)","journal-title":"Jama"},{"key":"4773_CR19","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.maturitas.2006.12.007","volume":"57","author":"DM Martin","year":"2007","unstructured":"D.M. Martin, G. Wittert, N.R. Burns, M.T. Haren, R. Sugarman, Testosterone and cognitive function in ageing men: data from the Florey Adelaide Male Ageing Study (FAMAS). Maturitas. 57, 182\u2013194 (2007)","journal-title":"Maturitas"},{"key":"4773_CR20","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/S2213-8587(17)30416-3","volume":"6","author":"BB Yeap","year":"2018","unstructured":"B.B. Yeap, S.T. Page, M. Grossmann, Testosterone treatment in older men: clinical implications and unresolved questions from the Testosterone Trials. lancet Diabetes Endocrinol. 6, 659\u2013672 (2018)","journal-title":"lancet Diabetes Endocrinol."},{"key":"4773_CR21","doi-asserted-by":"crossref","unstructured":"C.D.J. Kusters, K.C. Paul, A.T. Lu, L. Ferruci, B.R. Ritz, A.M. Binder et al., Higher testosterone and testosterone\/estradiol ratio in men are associated with decreased Pheno-\/GrimAge and DNA-methylation based PAI1. GeroScience. 2023","DOI":"10.1007\/s11357-023-00832-3"},{"key":"4773_CR22","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1210\/jc.2009-2354","volume":"95","author":"S Bhasin","year":"2010","unstructured":"S. Bhasin, G.R. Cunningham, F.J. Hayes, A.M. Matsumoto, P.J. Snyder, R.S. Swerdloff et al., Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 95, 2536\u20132559 (2010)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4773_CR23","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1210\/jc.2018-00229","volume":"103","author":"S Bhasin","year":"2018","unstructured":"S. Bhasin, J.P. Brito, G.R. Cunningham, F.J. Hayes, H.N. Hodis, A.M. Matsumoto et al., Testosterone Therapy in Men With Hypogonadism: An Endocrine Society* Clinical Practice Guideline. J. Clin. Endocrinol. Metabolism. 103, 1715\u20131744 (2018)","journal-title":"J. Clin. Endocrinol. Metabolism"},{"key":"4773_CR24","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1111\/andr.12770","volume":"8","author":"G Corona","year":"2020","unstructured":"G. Corona, D.G. Goulis, I. Huhtaniemi, M. Zitzmann, J. Toppari, G. Forti et al., European Academy of Andrology (EAA) guidelines on investigation, treatment and monitoring of functional hypogonadism in males: Endorsing organization: European Society of Endocrinology. Andrology. 8, 970\u2013987 (2020)","journal-title":"Andrology"},{"key":"4773_CR25","first-page":"14","volume":"4","author":"N Matthew","year":"2024","unstructured":"N. Matthew, C. David, Hypogonadism: cardiometabolism and gonadal function in men. Metabolism Target. Organ. Damage. 4, 14 (2024)","journal-title":"Metabolism Target. Organ. Damage"},{"key":"4773_CR26","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1056\/NEJMp1506632","volume":"373","author":"CP Nguyen","year":"2015","unstructured":"C.P. Nguyen, M.S. Hirsch, D. Moeny, S. Kaul, M. Mohamoud, H.V. Joffe, Testosterone and Age-Related Hypogonadism--FDA Concerns. N Engl. J. Med. 373, 689\u2013691 (2015)","journal-title":"N Engl. J. Med."},{"key":"4773_CR27","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/ki.1977.134","volume":"12","author":"DC Cattran","year":"1977","unstructured":"D.C. Cattran, S.S. Fenton, D.R. Wilson, D. Oreopoulos, A. Shimizu, R.M. Richardson, A controlled trial of nondrolone decanoate in the treatment of uremic anemia. Kidney Int. 12, 430\u2013437 (1977)","journal-title":"Kidney Int."},{"key":"4773_CR28","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.1210\/jcem.86.9.7821","volume":"86","author":"LP Ly","year":"2001","unstructured":"L.P. Ly, M. Jimenez, T.N. Zhuang, D.S. Celermajer, A.J. Conway, D.J. Handelsman, A double-blind, placebo-controlled, randomized clinical trial of transdermal dihydrotestosterone gel on muscular strength, mobility, and quality of life in older men with partial androgen deficiency. J. Clin. Endocrinol. Metab. 86, 4078\u20134088 (2001)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4773_CR29","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1212\/01.WNL.0000165995.98986.F1","volume":"64","author":"MM Cherrier","year":"2005","unstructured":"M.M. Cherrier, A.M. Matsumoto, J.K. Amory, S. Asthana, W. Bremner, E.R. Peskind et al., Testosterone improves spatial memory in men with Alzheimer disease and mild cognitive impairment. Neurology. 64, 2063\u20132068 (2005)","journal-title":"Neurology"},{"key":"4773_CR30","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.biopsych.2005.04.003","volume":"58","author":"J van Honk","year":"2005","unstructured":"van J. Honk, J.S. Peper, D.J. Schutter, Testosterone reduces unconscious fear but not consciously experienced anxiety: implications for the disorders of fear and anxiety. Biol. Psychiatry. 58, 218\u2013225 (2005)","journal-title":"Biol. Psychiatry"},{"key":"4773_CR31","doi-asserted-by":"publisher","first-page":"337","DOI":"10.2174\/1871527315666151110125704","volume":"15","author":"EJ Wahjoepramono","year":"2016","unstructured":"E.J. Wahjoepramono, P.R. Asih, V. Aniwiyanti, K. Taddei, S.S. Dhaliwal, S.J. Fuller et al., The Effects of Testosterone Supplementation on Cognitive Functioning in Older Men. CNS Neurol. Disord Drug Targets. 15, 337\u2013343 (2016)","journal-title":"CNS Neurol. Disord Drug Targets"},{"key":"4773_CR32","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1001\/jamainternmed.2016.9540","volume":"177","author":"CN Roy","year":"2017","unstructured":"C.N. Roy, P.J. Snyder, A.J. Stephens-Shields, A.S. Artz, S. Bhasin, H.J. Cohen et al., Association of Testosterone Levels With Anemia in Older Men: A Controlled Clinical Trial. JAMA Intern. Med. 177, 480\u2013490 (2017)","journal-title":"JAMA Intern. Med."},{"key":"4773_CR33","first-page":"583","volume":"102","author":"TW Storer","year":"2017","unstructured":"T.W. Storer, S. Basaria, T. Traustadottir, S.M. Harman, K. Pencina, Z. Li et al., Effects of Testosterone Supplementation for 3 Years on Muscle Performance and Physical Function in Older Men. J. Clin. Endocrinol. Metab. 102, 583\u2013593 (2017)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4773_CR34","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1210\/jc.2017-01902","volume":"103","author":"T Traustad\u00f3ttir","year":"2018","unstructured":"T. Traustad\u00f3ttir, S.M. Harman, P. Tsitouras, K.M. Pencina, Z. Li, T.G. Travison et al., Long-Term Testosterone Supplementation in Older Men Attenuates Age-Related Decline in Aerobic Capacity. J. Clin. Endocrinol. Metab. 103, 2861\u20132869 (2018)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4773_CR35","doi-asserted-by":"publisher","first-page":"104693","DOI":"10.1016\/j.psyneuen.2020.104693","volume":"117","author":"HH Kutlikova","year":"2020","unstructured":"H.H. Kutlikova, J.B. Durdiakov\u00e1, B. Wagner, M. Vl\u010dek, C. Eisenegger, C. Lamm et al., The effects of testosterone on the physiological response to social and somatic stressors. Psychoneuroendocrinology. 117, 104693 (2020)","journal-title":"Psychoneuroendocrinology"},{"key":"4773_CR36","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1159\/000324172","volume":"87","author":"J Bordallo","year":"2011","unstructured":"J. Bordallo, B. Cantabrana, L. Suarez, M. Sanchez, Testosterone inhibits cAMP-phosphodiesterases in heart extracts from rats and increases cAMP levels in isolated left atria. Pharmacology. 87, 155\u2013160 (2011)","journal-title":"Pharmacology"},{"key":"4773_CR37","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1586\/erc.11.25","volume":"9","author":"CT Nguyen","year":"2011","unstructured":"C.T. Nguyen, A. Aaronson, R.P. Morrissey, M. Agarwal, R.D. Willix, E.R. Schwarz, Myths and truths of growth hormone and testosterone therapy in heart failure. Expert Rev. Cardiovasc. Ther. 9, 711\u2013720 (2011)","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"4773_CR38","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1042\/CS20170090","volume":"131","author":"AK Lucas-Herald","year":"2017","unstructured":"A.K. Lucas-Herald, R. Alves-Lopes, A.C. Montezano, S.F. Ahmed, R.M. Touyz, Genomic and non-genomic effects of androgens in the cardiovascular system: clinical implications. Clin. Sci. (Lond). 131, 1405\u20131418 (2017)","journal-title":"Clin. Sci. (Lond)"},{"key":"4773_CR39","doi-asserted-by":"crossref","unstructured":"M.J. Budoff, S.S. Ellenberg, C.E. Lewis, E.R. 3 Mohler rd, N.K. Wenger, S. Bhasin et al., Testosterone Treatment and Coronary Artery Plaque Volume in Older Men With Low Testosterone. JAMA 317, 708\u2013716 (2017)","DOI":"10.1001\/jama.2016.21043"},{"key":"4773_CR40","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa2215025","volume":"389","author":"AM Lincoff","year":"2023","unstructured":"A.M. Lincoff, S. Bhasin, P. Flevaris, M. Mitchell Lisa, S. Basaria, E. Boden William et al., Cardiovascular Safety of Testosterone-Replacement Therapy. N. Engl. J. Med. 389, 107\u2013117 (2023)","journal-title":"N. Engl. J. Med."},{"key":"4773_CR41","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1161\/01.CIR.91.11.2742","volume":"91","author":"AA Ajayi","year":"1995","unstructured":"A.A. Ajayi, R. Mathur, P.V. Halushka, Testosterone increases human platelet thromboxane A2 receptor density and aggregation responses. Circulation. 91, 2742\u20132747 (1995)","journal-title":"Circulation"},{"key":"4773_CR42","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1194\/jlr.M600135-JLR200","volume":"47","author":"AC Casquero","year":"2006","unstructured":"A.C. Casquero, J.A. Berti, A.G. Salerno, E.J. Bighetti, P.M. Cazita, D.F. Ketelhuth et al., Atherosclerosis is enhanced by testosterone deficiency and attenuated by CETP expression in transgenic mice. J. Lipid Res. 47, 1526\u20131534 (2006)","journal-title":"J. Lipid Res."},{"key":"4773_CR43","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1210\/en.2009-1048","volume":"151","author":"J Yu","year":"2010","unstructured":"J. Yu, M. Akishita, M. Eto, S. Ogawa, B.K. Son, S. Kato et al., Androgen receptor-dependent activation of endothelial nitric oxide synthase in vascular endothelial cells: role of phosphatidylinositol 3-kinase\/akt pathway. Endocrinology. 151, 1822\u20131828 (2010)","journal-title":"Endocrinology"},{"key":"4773_CR44","doi-asserted-by":"publisher","first-page":"23751","DOI":"10.1073\/pnas.1915075117","volume":"117","author":"E Mackey","year":"2020","unstructured":"E. Mackey, K.M. Thelen, V. Bali, M. Fardisi, M. Trowbridge, C.L. Jordan et al., Perinatal androgens organize sex differences in mast cells and attenuate anaphylaxis severity into adulthood. Proc. Natl. Acad. Sci. U.S.A. 117, 23751\u201323761 (2020)","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"4773_CR45","doi-asserted-by":"crossref","unstructured":"A.M. Warren, M. Grossmann, Haematological actions of androgens. Best practice & research Clinical endocrinology & metabolism. 2022;36:101653","DOI":"10.1016\/j.beem.2022.101653"},{"key":"4773_CR46","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/1741-7015-11-108","volume":"11","author":"L Xu","year":"2013","unstructured":"L. Xu, G. Freeman, B.J. Cowling, C.M. Schooling, Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials. BMC Med. 11, 108 (2013)","journal-title":"BMC Med."},{"key":"4773_CR47","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/cen.13084","volume":"85","author":"SG Albert","year":"2016","unstructured":"S.G. Albert, J.E. Morley, Testosterone therapy, association with age, initiation and mode of therapy with cardiovascular events: a systematic review. Clin. Endocrinol. 85, 436\u2013443 (2016)","journal-title":"Clin. Endocrinol."},{"key":"4773_CR48","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1001\/jama.2013.280386","volume":"310","author":"R Vigen","year":"2013","unstructured":"R. Vigen, C.I. O\u2019Donnell, A.E. Bar\u00f3n, G.K. Grunwald, T.M. Maddox, S.M. Bradley et al., Association of Testosterone Therapy With Mortality, Myocardial Infarction, and Stroke in Men With Low Testosterone Levels. JAMA 310, 1829\u20131836 (2013)","journal-title":"JAMA"},{"key":"4773_CR49","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.eururo.2014.03.038","volume":"66","author":"JM Dupree","year":"2014","unstructured":"J.M. Dupree, R. Ramasamy, J.R. Kovac, G. Langille, L.I. Lipshultz, Re, Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men. Eur. Urol. 66, 175\u2013176 (2014)","journal-title":"Eur. Urol."},{"key":"4773_CR50","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S2213-8587(16)00112-1","volume":"4","author":"CJ Wallis","year":"2016","unstructured":"C.J. Wallis, K. Lo, Y. Lee, Y. Krakowsky, A. Garbens, R. Satkunasivam et al., Survival and cardiovascular events in men treated with testosterone replacement therapy: an intention-to-treat observational cohort study. lancet Diabetes Endocrinol. 4, 498\u2013506 (2016)","journal-title":"lancet Diabetes Endocrinol."},{"key":"4773_CR51","doi-asserted-by":"crossref","unstructured":"M. Abd Alamir, S.S. Ellenberg, R.S. Swerdloff, N.K. Wenger, E.R. 3 Mohler rd, C.E. Lewis et al., The Cardiovascular Trial of the Testosterone Trials: rationale, design, and baseline data of a clinical trial using computed tomographic imaging to assess the progression of coronary atherosclerosis. Coron. Artery Dis. 27, 95\u2013103 (2016)","DOI":"10.1097\/MCA.0000000000000321"},{"key":"4773_CR52","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1001\/jama.2015.8881","volume":"314","author":"S Basaria","year":"2015","unstructured":"S. Basaria, S.M. Harman, T.G. Travison, H. Hodis, P. Tsitouras, M. Budoff et al., Effects of Testosterone Administration for 3 Years on Subclinical Atherosclerosis Progression in Older Men With Low or Low-Normal Testosterone Levels: A Randomized Clinical Trial. Jama. 314, 570\u2013581 (2015)","journal-title":"Jama"},{"key":"4773_CR53","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.acuro.2017.08.003","volume":"42","author":"A Alc\u00e1ntara Montero","year":"2018","unstructured":"A. Alc\u00e1ntara Montero, Management of male hypogonadism and testosterone therapy: European Association of Urology position statement on the role of the urologist. Actas Urol. Esp. 42, 212\u2013213 (2018)","journal-title":"Actas Urol. Esp."},{"key":"4773_CR54","doi-asserted-by":"publisher","first-page":"126","DOI":"10.7326\/M19-0882","volume":"172","author":"A Qaseem","year":"2020","unstructured":"A. Qaseem, C.A. Horwitch, S. Vijan, I. Etxeandia-Ikobaltzeta, D. Kansagara, M.A. Forciea et al., Testosterone Treatment in Adult Men With Age-Related Low Testosterone: A Clinical Guideline From the American College of Physicians. Ann. Intern. Med. 172, 126\u2013133 (2020)","journal-title":"Ann. Intern. Med."},{"key":"4773_CR55","first-page":"121","volume":"42","author":"Society of Geriatrics CMA","year":"2023","unstructured":"Society of Geriatrics CMA, Editorial Board of Chinese Journal of Geriatrics,. Chinese clinical practice guideline for frailty related endocrine hormone management in the elderly. Chin. J. Geriatr. 42, 121\u2013143 (2023)","journal-title":"Chin. J. Geriatr."},{"key":"4773_CR56","doi-asserted-by":"publisher","first-page":"e381","DOI":"10.1016\/S2666-7568(22)00096-4","volume":"3","author":"J Hudson","year":"2022","unstructured":"J. Hudson, M. Cruickshank, R. Quinton, L. Aucott, M. Aceves-Martins, K. Gillies et al., Adverse cardiovascular events and mortality in men during testosterone treatment: an individual patient and aggregate data meta-analysis. lancet Healthy Longev. 3, e381\u2013e93 (2022)","journal-title":"lancet Healthy Longev."},{"key":"4773_CR57","unstructured":"Centre for Reviews, and Dissemination Systematic reviews: CRD\u2019s guidance for undertaking systematic reviews in health care. 2009"},{"key":"4773_CR58","doi-asserted-by":"crossref","unstructured":"J.P.T.T.J. Higgins, J. Chandler, M. Cumpston, T. Li, M.J. Page, V.A. Welch, Cochrane Handbook for Systematic Reviews of Interventions, 6.0 ed Cochrane. 2019","DOI":"10.1002\/9781119536604"},{"key":"4773_CR59","doi-asserted-by":"publisher","first-page":"b2700","DOI":"10.1136\/bmj.b2700","volume":"339","author":"A Liberati","year":"2009","unstructured":"A. Liberati, D.G. Altman, J. Tetzlaff, C. Mulrow, P.C. G\u00f8tzsche, J.P. Ioannidis et al., The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (Clinical Res. ed). 339, b2700 (2009)","journal-title":"BMJ (Clinical Res. ed)"},{"key":"4773_CR60","doi-asserted-by":"publisher","first-page":"82","DOI":"10.2337\/dc15-1518","volume":"39","author":"S Dhindsa","year":"2016","unstructured":"S. Dhindsa, H. Ghanim, M. Batra, N.D. Kuhadiya, S. Abuaysheh, S. Sandhu et al., Insulin Resistance and Inflammation in Hypogonadotropic Hypogonadism and Their Reduction After Testosterone Replacement in Men With Type 2 Diabetes. Diabetes care. 39, 82\u201391 (2016)","journal-title":"Diabetes care"},{"key":"4773_CR61","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1161\/01.CIR.99.13.1666","volume":"99","author":"GM Rosano","year":"1999","unstructured":"G.M. Rosano, F. Leonardo, P. Pagnotta, F. Pelliccia, G. Panina, E. Cerquetani et al., Acute anti-ischemic effect of testosterone in men with coronary artery disease. Circulation. 99, 1666\u20131670 (1999)","journal-title":"Circulation"},{"key":"4773_CR62","unstructured":"J.P.T.S.J. Higgins, M.J. Page, R.G. Elbers, J.A.C. Sterne, Chapter 8: Assessing risk of bias in a randomized trial. In: Higgins JPT TJ, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor. Cochrane Handbook for Systematic Reviews of Interventions version 63. Cochrane2022"},{"key":"4773_CR63","unstructured":"J.P.T.G.S. Higgins, Chapter 7: Selecting studies and collecting data. Cochrane handbook for systematic reviews of interventions Version 510. The Cochrane Collaboration2011"},{"key":"4773_CR64","doi-asserted-by":"publisher","first-page":"508","DOI":"10.5534\/wjmh.221027","volume":"41","author":"G Hackett","year":"2023","unstructured":"G. Hackett, M. Kirby, R.W. Rees, T.H. Jones, A. Muneer, M. Livingston et al., The British Society for Sexual Medicine Guidelines on Male Adult Testosterone Deficiency, with Statements for Practice. world J. men\u2019s health. 41, 508\u2013537 (2023)","journal-title":"world J. men\u2019s health"},{"key":"4773_CR65","first-page":"904","volume":"56","author":"M Rabijewski","year":"2005","unstructured":"M. Rabijewski, W. Zgliczy\u0144ski, [Positive effects of DHEA therapy on insulin resistance and lipids in men with angiographically verified coronary heart disease\u2013preliminary study]. Endokrynologia Polska. 56, 904\u2013910 (2005)","journal-title":"Endokrynologia Polska"},{"key":"4773_CR66","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/j.1365-2265.2006.02454.x","volume":"64","author":"V Martina","year":"2006","unstructured":"V. Martina, A. Benso, V.R. Gigliardi, A. Masha, C. Origlia, R. Granata et al., Short-term dehydroepiandrosterone treatment increases platelet cGMP production in elderly male subjects. Clin. Endocrinol. 64, 260\u2013264 (2006)","journal-title":"Clin. Endocrinol."},{"key":"4773_CR67","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1111\/j.1743-6109.2010.01931.x","volume":"7","author":"A Aversa","year":"2010","unstructured":"A. Aversa, R. Bruzziches, D. Francomano, G. Rosano, A.M. Isidori, A. Lenzi et al., Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 24-month, randomized, double-blind, placebo-controlled study. J. Sex. Med. 7, 3495\u20133503 (2010)","journal-title":"J. Sex. Med."},{"key":"4773_CR68","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ijcard.2008.12.107","volume":"142","author":"A Cornoldi","year":"2010","unstructured":"A. Cornoldi, G. Caminiti, G. Marazzi, C. Vitale, R. Patrizi, M. Volterrani et al., Effects of chronic testosterone administration on myocardial ischemia, lipid metabolism and insulin resistance in elderly male diabetic patients with coronary artery disease. Int. J. Cardiol. 142, 50\u201355 (2010)","journal-title":"Int. J. Cardiol."},{"key":"4773_CR69","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0002-9343(01)00813-0","volume":"111","author":"PJ Snyder","year":"2001","unstructured":"P.J. Snyder, H. Peachey, J.A. Berlin, D. Rader, D. Usher, L. Loh et al., Effect of transdermal testosterone treatment on serum lipid and apolipoprotein levels in men more than 65 years of age. Am. J. Med. 111, 255\u2013260 (2001)","journal-title":"Am. J. Med."},{"key":"4773_CR70","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1067\/mhj.2002.120144","volume":"143","author":"PD Thompson","year":"2002","unstructured":"P.D. Thompson, A.W. Ahlberg, N.M. Moyna, B. Duncan, M. Ferraro-Borgida, C.M. White et al., Effect of intravenous testosterone on myocardial ischemia in men with coronary artery disease. Am. Heart J. 143, 249\u2013256 (2002)","journal-title":"Am. Heart J."},{"key":"4773_CR71","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1210\/jc.2003-031110","volume":"89","author":"JK Amory","year":"2004","unstructured":"J.K. Amory, N.B. Watts, K.A. Easley, P.R. Sutton, B.D. Anawalt, A.M. Matsumoto et al., Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone. J. Clin. Endocrinol. Metab. 89, 503\u2013510 (2004)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4773_CR72","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1001\/jama.2007.51","volume":"299","author":"MH Emmelot-Vonk","year":"2008","unstructured":"M.H. Emmelot-Vonk, H.J. Verhaar, H.R. Nakhai Pour, A. Aleman, T.M. Lock, J.L. Bosch et al., Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial. Jama. 299, 39\u201352 (2008)","journal-title":"Jama"},{"key":"4773_CR73","doi-asserted-by":"publisher","first-page":"681","DOI":"10.7326\/0003-4819-157-10-201211200-00004","volume":"157","author":"M Spitzer","year":"2012","unstructured":"M. Spitzer, S. Basaria, T.G. Travison, M.N. Davda, A. Paley, B. Cohen et al., Effect of testosterone replacement on response to sildenafil citrate in men with erectile dysfunction: a parallel, randomized trial. Ann. Intern. Med. 157, 681\u2013691 (2012)","journal-title":"Ann. Intern. Med."},{"key":"4773_CR74","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.4158\/EP13357.OR","volume":"20","author":"M Maggio","year":"2014","unstructured":"M. Maggio, P.J. Snyder, De F. Vita, G.P. Ceda, Y. Milaneschi, F. Lauretani et al., Effects of transdermal testosterone treatment on inflammatory markers in elderly males. Endocr. practice: official J. Am. Coll. Endocrinol. Am. Association Clin. Endocrinologists. 20, 1170\u20131177 (2014)","journal-title":"Endocr. practice: official J. Am. Coll. Endocrinol. Am. Association Clin. Endocrinologists"},{"key":"4773_CR75","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1056\/NEJMoa1506119","volume":"374","author":"PJ Snyder","year":"2016","unstructured":"P.J. Snyder, S. Bhasin, G.R. Cunningham, A.M. Matsumoto, A.J. Stephens-Shields, J.A. Cauley et al., Effects of Testosterone Treatment in Older Men. N. Engl. J. Med. 374, 611\u2013624 (2016)","journal-title":"N. Engl. J. Med."},{"key":"4773_CR76","doi-asserted-by":"crossref","unstructured":"E.R. 3 Mohler rd, S.S. Ellenberg, C.E. Lewis, N.K. Wenger, M.J. Budoff, M.R. Lewis et al., The Effect of Testosterone on Cardiovascular Biomarkers in the Testosterone Trials. J. Clin. Endocrinol. Metab. 103, 681\u2013688 (2018)","DOI":"10.1210\/jc.2017-02243"},{"key":"4773_CR77","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0002-9149(98)00880-7","volume":"83","author":"CM Webb","year":"1999","unstructured":"C.M. Webb, D.L. Adamson, de D. Zeigler, P. Collins, Effect of acute testosterone on myocardial ischemia in men with coronary artery disease. Am. J. Cardiol. 83, 437\u2013439 (1999). a9","journal-title":"Am. J. Cardiol."},{"key":"4773_CR78","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1161\/01.CIR.102.16.1906","volume":"102","author":"KM English","year":"2000","unstructured":"K.M. English, R.P. Steeds, T.H. Jones, M.J. Diver, K.S. Channer, Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: A randomized, double-blind, placebo-controlled study. Circulation. 102, 1906\u20131911 (2000)","journal-title":"Circulation"},{"key":"4773_CR79","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1210\/jc.2003-031069","volume":"89","author":"CJ Malkin","year":"2004","unstructured":"C.J. Malkin, P.J. Pugh, R.D. Jones, D. Kapoor, K.S. Channer, T.H. Jones, The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. J. Clin. Endocrinol. Metab. 89, 3313\u20133318 (2004)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4773_CR80","first-page":"871","volume":"90","author":"CJ Malkin","year":"2004","unstructured":"C.J. Malkin, P.J. Pugh, P.D. Morris, K.E. Kerry, R.D. Jones, T.H. Jones et al., Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life. Heart (British Cardiac Society). 90, 871\u2013876 (2004)","journal-title":"Heart (British Cardiac Society)"},{"key":"4773_CR81","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/eurheartj\/ehi443","volume":"27","author":"CJ Malkin","year":"2006","unstructured":"C.J. Malkin, P.J. Pugh, J.N. West, van E.J. Beek, T.H. Jones, K.S. Channer, Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial. Eur. Heart J. 27, 57\u201364 (2006)","journal-title":"Eur. Heart J."},{"key":"4773_CR82","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1530\/EJE-06-0737","volume":"156","author":"D Kapoor","year":"2007","unstructured":"D. Kapoor, S. Clarke, R. Stanworth, K.S. Channer, T.H. Jones, The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes. Eur. J. Endocrinol. 156, 595\u2013602 (2007)","journal-title":"Eur. J. Endocrinol."},{"key":"4773_CR83","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.amjcard.2007.09.114","volume":"101","author":"CM Webb","year":"2008","unstructured":"C.M. Webb, A.G. Elkington, M.M. Kraidly, N. Keenan, D.J. Pennell, P. Collins, Effects of oral testosterone treatment on myocardial perfusion and vascular function in men with low plasma testosterone and coronary heart disease. Am. J. Cardiol. 101, 618\u2013624 (2008)","journal-title":"Am. J. Cardiol."},{"key":"4773_CR84","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1530\/EJE-09-0092","volume":"161","author":"A Mathur","year":"2009","unstructured":"A. Mathur, C. Malkin, B. Saeed, R. Muthusamy, T.H. Jones, K. Channer, Long-term benefits of testosterone replacement therapy on angina threshold and atheroma in men. Eur. J. Endocrinol. 161, 443\u2013449 (2009)","journal-title":"Eur. J. Endocrinol."},{"key":"4773_CR85","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1210\/jc.2009-1251","volume":"95","author":"U Srinivas-Shankar","year":"2010","unstructured":"U. Srinivas-Shankar, S.A. Roberts, M.J. Connolly, M.D. O\u2019Connell, J.E. Adams, J.A. Oldham et al., Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study. J. Clin. Endocrinol. Metab. 95, 639\u2013650 (2010)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4773_CR86","doi-asserted-by":"publisher","first-page":"828","DOI":"10.2337\/dc10-1233","volume":"34","author":"TH Jones","year":"2011","unstructured":"T.H. Jones, S. Arver, H.M. Behre, J. Buvat, E. Meuleman, I. Moncada et al., Testosterone replacement in hypogonadal men with type 2 diabetes and\/or metabolic syndrome (the TIMES2 study). Diabetes Care. 34, 828\u2013837 (2011)","journal-title":"Diabetes Care"},{"key":"4773_CR87","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1111\/bju.12037","volume":"111","author":"WS Tan","year":"2013","unstructured":"W.S. Tan, W.Y. Low, C.J. Ng, W.K. Tan, S.F. Tong, C. Ho et al., Efficacy and safety of long-acting intramuscular testosterone undecanoate in aging men: a randomised controlled study. BJU Int. 111, 1130\u20131140 (2013)","journal-title":"BJU Int."},{"key":"4773_CR88","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1111\/j.1365-2265.2010.03845.x","volume":"73","author":"SY Kalinchenko","year":"2010","unstructured":"S.Y. Kalinchenko, Y.A. Tishova, G.J. Mskhalaya, L.J. Gooren, E.J. Giltay, F. Saad, Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study. Clin. Endocrinol. 73, 602\u2013612 (2010)","journal-title":"Clin. Endocrinol."},{"key":"4773_CR89","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S2213-8587(20)30367-3","volume":"9","author":"G Wittert","year":"2021","unstructured":"G. Wittert, K. Bracken, K.P. Robledo, M. Grossmann, B.B. Yeap, D.J. Handelsman et al., Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial. lancet Diabetes Endocrinol. 9, 32\u201345 (2021)","journal-title":"lancet Diabetes Endocrinol."},{"key":"4773_CR90","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/j.1464-410X.2011.10755.x","volume":"110","author":"CC Ho","year":"2012","unstructured":"C.C. Ho, S.F. Tong, W.Y. Low, C.J. Ng, E.M. Khoo, V.K. Lee et al., A randomized, double-blind, placebo-controlled trial on the effect of long-acting testosterone treatment as assessed by the Aging Male Symptoms scale. BJU Int. 110, 260\u2013265 (2012)","journal-title":"BJU Int."},{"key":"4773_CR91","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1056\/NEJMoa1000485","volume":"363","author":"S Basaria","year":"2010","unstructured":"S. Basaria, A.D. Coviello, T.G. Travison, T.W. Storer, W.R. Farwell, A.M. Jette et al., Adverse events associated with testosterone administration. N Engl. J. Med. 363, 109\u2013122 (2010)","journal-title":"N Engl. J. Med."},{"key":"4773_CR92","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/and.12305","volume":"47","author":"M Naifar","year":"2015","unstructured":"M. Naifar, N. Rekik, M. Messedi, K. Chaabouni, A. Lahiani, M. Turki et al., Male hypogonadism and metabolic syndrome. Andrologia. 47, 579\u2013586 (2015)","journal-title":"Andrologia"},{"key":"4773_CR93","first-page":"320","volume":"50","author":"GM Rosano","year":"2015","unstructured":"G.M. Rosano, C. Vitale, M. Fini, Testosterone in men with hypogonadism and high cardiovascular risk. Pros Endocr. 50, 320\u2013325 (2015)","journal-title":"Pros Endocr."},{"key":"4773_CR94","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1001\/archinte.166.15.1660","volume":"166","author":"MM Shores","year":"2006","unstructured":"M.M. Shores, A.M. Matsumoto, K.L. Sloan, D.R. Kivlahan, Low serum testosterone and mortality in male veterans. Arch. Intern. Med. 166, 1660\u20131665 (2006)","journal-title":"Arch. Intern. Med."},{"key":"4773_CR95","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1210\/jc.2007-1792","volume":"93","author":"GA Laughlin","year":"2008","unstructured":"G.A. Laughlin, E. Barrett-Connor, J. Bergstrom, Low serum testosterone and mortality in older men. J. Clin. Endocrinol. Metab. 93, 68\u201375 (2008)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4773_CR96","first-page":"870","volume":"97","author":"JB Ruige","year":"2011","unstructured":"J.B. Ruige, A.M. Mahmoud, De D. Bacquer, J.M. Kaufman, Endogenous testosterone and cardiovascular disease in healthy men: a meta-analysis. Heart (British Cardiac Society). 97, 870\u2013875 (2011)","journal-title":"Heart (British Cardiac Society)"},{"key":"4773_CR97","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/S2213-8587(19)30189-5","volume":"7","author":"RM Islam","year":"2019","unstructured":"R.M. Islam, R.J. Bell, S. Green, M.J. Page, S.R. Davis, Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data. lancet Diabetes Endocrinol. 7, 754\u2013766 (2019)","journal-title":"lancet Diabetes Endocrinol."},{"key":"4773_CR98","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1007\/s11255-021-02876-w","volume":"53","author":"SH Kim","year":"2021","unstructured":"S.H. Kim, J.J. Park, K.H. Kim, H.J. Yang, D.S. Kim, C.H. Lee et al., Efficacy of testosterone replacement therapy for treating metabolic disturbances in late-onset hypogonadism: a systematic review and meta-analysis. Int. Urol. Nephrol. 53, 1733\u20131746 (2021)","journal-title":"Int. Urol. Nephrol."},{"key":"4773_CR99","doi-asserted-by":"publisher","first-page":"58914","DOI":"10.7554\/eLife.58914","volume":"9","author":"P Mohammadi-Shemirani","year":"2020","unstructured":"P. Mohammadi-Shemirani, M. Chong, M. Pigeyre, R.W. Morton, H.C. Gerstein, G. Par\u00e9, Effects of lifelong testosterone exposure on health and disease using Mendelian randomization. eLife. 9, 58914 (2020)","journal-title":"eLife"},{"key":"4773_CR100","doi-asserted-by":"publisher","first-page":"67m","DOI":"10.1016\/j.amjcard.2005.10.009","volume":"96","author":"R Shabsigh","year":"2005","unstructured":"R. Shabsigh, M. Katz, G. Yan, N. Makhsida, Cardiovascular issues in hypogonadism and testosterone therapy. Am. J. Cardiol. 96, 67m\u201372m (2005)","journal-title":"Am. J. Cardiol."},{"key":"4773_CR101","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1210\/jc.2009-1579","volume":"95","author":"S Basaria","year":"2010","unstructured":"S. Basaria, Androgen abuse in athletes: detection and consequences. J. Clin. Endocrinol. Metab. 95, 1533\u20131543 (2010)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4773_CR102","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/j.1365-2605.2012.01285.x","volume":"35","author":"R Haring","year":"2012","unstructured":"R. Haring, V. Xanthakis, A. Coviello, L. Sullivan, S. Bhasin, H. Wallaschofski et al., Clinical correlates of sex steroids and gonadotropins in men over the late adulthood: the Framingham Heart Study. Int. J. Androl. 35, 775\u2013782 (2012)","journal-title":"Int. J. Androl."},{"key":"4773_CR103","doi-asserted-by":"crossref","unstructured":"E. Bolu, A. Sonmez, S. Tapan, A. Taslipinar, A. Aydogdu, C. Meric et al., HDL cholesterol subfractions and the effect of testosterone replacement in hypogonadism. Hormone and metabolic research\u2009=\u2009Hormon- und Stoffwechselforschung\u2009=\u2009Hormones et metabolisme. 2013;45:443-8","DOI":"10.1055\/s-0033-1343447"},{"key":"4773_CR104","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1046\/j.1365-2265.1998.3721211.x","volume":"48","author":"KC Tan","year":"1998","unstructured":"K.C. Tan, S.W. Shiu, R.W. Pang, A.W. Kung, Effects of testosterone replacement on HDL subfractions and apolipoprotein A-I containing lipoproteins. Clin. Endocrinol. 48, 187\u2013194 (1998)","journal-title":"Clin. Endocrinol."},{"key":"4773_CR105","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1194\/jlr.P026005","volume":"53","author":"KB Rubinow","year":"2012","unstructured":"K.B. Rubinow, T. Vaisar, C. Tang, A.M. Matsumoto, J.W. Heinecke, S.T. Page, Testosterone replacement in hypogonadal men alters the HDL proteome but not HDL cholesterol efflux capacity. J. Lipid Res. 53, 1376\u20131383 (2012)","journal-title":"J. Lipid Res."},{"key":"4773_CR106","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1210\/jc.2010-1167","volume":"96","author":"MD O\u2019Connell","year":"2011","unstructured":"M.D. O\u2019Connell, S.A. Roberts, U. Srinivas-Shankar, A. Tajar, M.J. Connolly, J.E. Adams et al., Do the effects of testosterone on muscle strength, physical function, body composition, and quality of life persist six months after treatment in intermediate-frail and frail elderly men? J. Clin. Endocrinol. Metab. 96, 454\u2013458 (2011)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4773_CR107","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1128\/MCB.24.7.2593-2604.2004","volume":"24","author":"CY Hong","year":"2004","unstructured":"C.Y. Hong, J.H. Park, R.S. Ahn, S.Y. Im, H.S. Choi, J. Soh et al., Molecular mechanism of suppression of testicular steroidogenesis by proinflammatory cytokine tumor necrosis factor alpha. Mol. Cell. Biol. 24, 2593\u20132604 (2004)","journal-title":"Mol. Cell. Biol."},{"key":"4773_CR108","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.fertnstert.2008.05.040","volume":"92","author":"JJ Corrales","year":"2009","unstructured":"J.J. Corrales, M. Almeida, J.M. Miralles, A. Orfao, Persistence of androgenic effects on the production of proinflammatory cytokines by circulating antigen-presenting cells after withdrawal of testosterone treatment in aging type 2 diabetic men with partial androgen deficiency. Fertil. Steril. 92, 311\u2013319 (2009)","journal-title":"Fertil. Steril."},{"key":"4773_CR109","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1677\/JOE-10-0057","volume":"206","author":"MP Corcoran","year":"2010","unstructured":"M.P. Corcoran, M. Meydani, A.H. Lichtenstein, E.J. Schaefer, A. Dillard, S. Lamon-Fava, Sex hormone modulation of proinflammatory cytokine and C-reactive protein expression in macrophages from older men and postmenopausal women. J. Endocrinol. 206, 217\u2013224 (2010)","journal-title":"J. Endocrinol."},{"key":"4773_CR110","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/cen.13049","volume":"85","author":"G Huang","year":"2016","unstructured":"G. Huang, T. Travison, M. Maggio, R.R. Edwards, S. Basaria, Effects of testosterone replacement on metabolic and inflammatory markers in men with opioid-induced androgen deficiency. Clin. Endocrinol. 85, 232\u2013238 (2016)","journal-title":"Clin. Endocrinol."},{"key":"4773_CR111","doi-asserted-by":"publisher","first-page":"e43053","DOI":"10.5812\/ijem.43053","volume":"15","author":"KY Chin","year":"2017","unstructured":"K.Y. Chin, S. Ima-Nirwana, The Effects of Testosterone Deficiency and Its Replacement on Inflammatory Markers in Rats: A Pilot Study. Int. J. Endocrinol. metabolism. 15, e43053 (2017)","journal-title":"Int. J. Endocrinol. metabolism"},{"key":"4773_CR112","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1177\/10742484211032402","volume":"26","author":"X Zhang","year":"2021","unstructured":"X. Zhang, H. Zhao, J. Horney, N. Johnson, F. Saad, K.S. Haider et al., Testosterone Deficiency, Long-Term Testosterone Therapy, and Inflammation. J. Cardiovasc. Pharmacol. Therap. 26, 638\u2013647 (2021)","journal-title":"J. Cardiovasc. Pharmacol. Therap."},{"key":"4773_CR113","doi-asserted-by":"publisher","first-page":"418","DOI":"10.23736\/S2724-6051.21.04307-X","volume":"74","author":"R Cannarella","year":"2022","unstructured":"R. Cannarella, F. Barbagallo, A. Crafa, L.M. Mongioi, A. Aversa, E. Greco et al., Testosterone replacement therapy in hypogonadal male patients with hypogonadism and heart failure: a meta-analysis of randomized controlled studies. Minerva Urol. Nephrol. 74, 418\u2013427 (2022)","journal-title":"Minerva Urol. Nephrol."},{"key":"4773_CR114","doi-asserted-by":"publisher","first-page":"e85805","DOI":"10.1371\/journal.pone.0085805","volume":"9","author":"WD Finkle","year":"2014","unstructured":"W.D. Finkle, S. Greenland, G.K. Ridgeway, J.L. Adams, M.A. Frasco, M.B. Cook et al., Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men. PLoS One. 9, e85805 (2014)","journal-title":"PLoS One"},{"key":"4773_CR115","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.jsxm.2022.05.145","volume":"19","author":"G Fallara","year":"2022","unstructured":"G. Fallara, E. Pozzi, F. Belladelli, C. Corsini, L. Boeri, P. Capogrosso et al., Cardiovascular Morbidity and Mortality in Men - Findings From a Meta-analysis on the Time-related Measure of Risk of Exogenous Testosterone. J. Sex. Med. 19, 1243\u20131254 (2022)","journal-title":"J. Sex. Med."},{"key":"4773_CR116","doi-asserted-by":"publisher","first-page":"bvaf002","DOI":"10.1210\/jendso\/bvaf002","volume":"9","author":"KM Pencina","year":"2025","unstructured":"K.M. Pencina, A.M. Lincoff, E.A. Klein, S.E. Nissen, Y.V. Shang, N. Khan et al., Testosterone Replacement Therapy and Risk of COVID-19 and Effect of COVID-19 on Testosterone\u2019s Treatment Effect. J. Endocr. Soc. 9, bvaf002 (2025)","journal-title":"J. Endocr. Soc."},{"key":"4773_CR117","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1093\/eurheartj\/ehv346","volume":"36","author":"R Sharma","year":"2015","unstructured":"R. Sharma, O.A. Oni, K. Gupta, G. Chen, M. Sharma, B. Dawn et al., Normalization of testosterone level is associated with reduced incidence of myocardial infarction and mortality in men. Eur. Heart J. 36, 2706\u20132715 (2015)","journal-title":"Eur. Heart J."},{"key":"4773_CR118","doi-asserted-by":"publisher","first-page":"e004880","DOI":"10.1161\/JAHA.116.004880","volume":"6","author":"R Sharma","year":"2017","unstructured":"R. Sharma, O.A. Oni, K. Gupta, M. Sharma, R. Sharma, V. Singh et al., Normalization of Testosterone Levels After Testosterone Replacement Therapy Is Associated With Decreased Incidence of Atrial Fibrillation. J. Am. Heart Association. 6, e004880 (2017)","journal-title":"J. Am. Heart Association"},{"key":"4773_CR119","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1111\/j.1540-8167.2009.01474.x","volume":"20","author":"T Tsuneda","year":"2009","unstructured":"T. Tsuneda, T. Yamashita, T. Kato, A. Sekiguchi, K. Sagara, H. Sawada et al., Deficiency of testosterone associates with the substrate of atrial fibrillation in the rat model. J. Cardiovasc. Electrophysiol. 20, 1055\u20131060 (2009)","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"4773_CR120","doi-asserted-by":"publisher","first-page":"102611","DOI":"10.1016\/j.eclinm.2024.102611","volume":"72","author":"C Tran","year":"2024","unstructured":"C. Tran, B.B. Yeap, J. Ball, D. Clayton-Chubb, S.M. Hussain, A. Brodtmann et al., Testosterone and the risk of incident atrial fibrillation in older men: further analysis of the ASPREE study. eClinicalMedicine. 72, 102611 (2024)","journal-title":"eClinicalMedicine"},{"key":"4773_CR121","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.hroo.2025.11.007","volume":"7","author":"A Venkatakrishnan","year":"2026","unstructured":"A. Venkatakrishnan, D. Srinivasan, A. Malik, M. Hazareh, M.A. Nizami, J.Y. Chen et al., Effect of estrogen and testosterone on cardiac electrophysiology and atrial fibrillation. Heart Rhythm O2. 7, 393\u2013403 (2026)","journal-title":"Heart Rhythm O2"},{"key":"4773_CR122","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.amjcard.2008.11.041","volume":"103","author":"B Charbit","year":"2009","unstructured":"B. Charbit, S. Christin-Ma\u00eetre, J.L. D\u00e9molis, E. Soustre, J. Young, C. Funck-Brentano, Effects of testosterone on ventricular repolarization in hypogonadic men. Am. J. Cardiol. 103, 887\u2013890 (2009)","journal-title":"Am. J. Cardiol."},{"key":"4773_CR123","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ijcha.2016.11.006","volume":"14","author":"G Tse","year":"2017","unstructured":"G. Tse, Y.W. Chan, W. Keung, B.P. Yan, Electrophysiological mechanisms of long and short QT syndromes. Int. J. Cardiol. Heart vasculature. 14, 8\u201313 (2017)","journal-title":"Int. J. Cardiol. Heart vasculature"},{"key":"4773_CR124","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1530\/eje.1.01848","volume":"152","author":"AM Smith","year":"2005","unstructured":"A.M. Smith, K.M. English, C.J. Malkin, R.D. Jones, T.H. Jones, K.S. Channer, Testosterone does not adversely affect fibrinogen or tissue plasminogen activator (tPA) and plasminogen activator inhibitor-1 (PAI-1) levels in 46 men with chronic stable angina. Eur. J. Endocrinol. 152, 285\u2013291 (2005)","journal-title":"Eur. J. Endocrinol."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04773-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-026-04773-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04773-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:02:11Z","timestamp":1791284531000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-026-04773-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":124,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4773"],"URL":"https:\/\/doi.org\/10.1007\/s12020-026-04773-7","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,6]]},"assertion":[{"value":"26 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable because this study is based exclusively on published literature.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Conflict of interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"329"}}